Trace Life Sciences

Trace Life Sciences is a specialized radiopharmaceutical company focused on the development, manufacturing, and distribution of advanced imaging agents for Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT). The company operates high-capacity radiopharmacies and state-of-the-art manufacturing facilities to support the clinical and commercial needs of the precision medicine industry. As a Contract Development and Manufacturing Organization (CDMO), Trace provides comprehensive services including radiochemistry development, clinical trial supply, and commercial-scale production of radiolabeled compounds. Their expertise spans multiple therapeutic areas, including oncology, neurology, and cardiology, facilitating high-quality diagnostic imaging for healthcare providers and pharmaceutical partners.